Renaissance Group LLC Jazz Pharmaceuticals PLC Transaction History

Renaissance Group LLC

$2.36 Billion
Q3 2024

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	SELL	$114.26 - $136.0 $263,026 - $313,072	-2,302 Reduced 5.62%	38,693 $4.76 Million
Q3 2023 Nov 13, 2023	SELL	$122.0 - $145.31 $215,818 - $257,053	-1,769 Reduced 4.14%	40,995 $5.31 Million
Q2 2023 Aug 10, 2023	SELL	$122.5 - $147.16 $105,717 - $126,999	-863 Reduced 1.98%	42,764 $5.3 Million
Q1 2023 May 12, 2023	SELL	$133.98 - $160.47 $159,034 - $190,477	-1,187 Reduced 2.65%	43,627 $6.38 Million
Q4 2022 Feb 14, 2023	SELL	$129.72 - $159.85 $246,078 - $303,235	-1,897 Reduced 4.06%	44,814 $7.14 Million
Q3 2022 Nov 14, 2022	SELL	$126.59 - $161.18 $260,522 - $331,708	-2,058 Reduced 4.22%	46,711 $6.23 Million
Q2 2022 Aug 15, 2022	SELL	$141.59 - $168.66 $1.55 Million - $1.84 Million	-10,928 Reduced 18.31%	48,769 $7.61 Million
Q1 2022 May 13, 2022	BUY	$129.64 - $160.7 $775,376 - $961,146	5,981 Added 11.13%	59,697 $9.29 Million
Q4 2021 Feb 11, 2022	SELL	$119.87 - $145.67 $1.73 Million - $2.1 Million	-14,405 Reduced 21.15%	53,716 $6.84 Million
Q3 2021 Nov 12, 2021	BUY	$128.64 - $184.79 $767,594 - $1.1 Million	5,967 Added 9.6%	68,121 $8.87 Million
Q2 2021 Aug 13, 2021	SELL	$160.2 - $186.42 $753,580 - $876,919	-4,704 Reduced 7.04%	62,154 $11 Million
Q1 2021 May 13, 2021	SELL	$150.19 - $173.5 $556,453 - $642,817	-3,705 Reduced 5.25%	66,858 $11 Million
Q4 2020 Feb 12, 2021	SELL	$140.71 - $165.05 $505,430 - $592,859	-3,592 Reduced 4.84%	70,563 $11.6 Million
Q3 2020 Nov 12, 2020	SELL	$105.46 - $144.13 $711,538 - $972,445	-6,747 Reduced 8.34%	74,155 $10.6 Million
Q2 2020 Aug 12, 2020	SELL	$95.68 - $121.88 $706,309 - $899,718	-7,382 Reduced 8.36%	80,902 $8.93 Million
Q1 2020 May 06, 2020	SELL	$87.74 - $152.74 $990,321 - $1.72 Million	-11,287 Reduced 11.34%	88,284 $8.81 Million
Q4 2019 Feb 12, 2020	SELL	$117.65 - $153.73 $690,958 - $902,856	-5,873 Reduced 5.57%	99,571 $14.9 Million
Q3 2019 Oct 31, 2019	BUY	$125.18 - $143.24 $463,666 - $530,560	3,704 Added 3.64%	105,444 $13.5 Million
Q2 2019 Aug 13, 2019	SELL	$125.55 - $144.48 $964,349 - $1.11 Million	-7,681 Reduced 7.02%	101,740 $14.5 Million
Q1 2019 Apr 30, 2019	BUY	$121.81 - $142.95 $485,169 - $569,369	3,983 Added 3.78%	109,421 $15.6 Million
Q4 2018 Feb 04, 2019	SELL	$115.94 - $166.74 $786,884 - $1.13 Million	-6,787 Reduced 6.05%	105,438 $13.1 Million
Q3 2018 Nov 13, 2018	SELL	$161.01 - $180.57 $1.35 Million - $1.51 Million	-8,368 Reduced 6.94%	112,225 $18.9 Million
Q2 2018 Aug 07, 2018	SELL	$146.33 - $183.18 $43,899 - $54,954	-300 Reduced 0.25%	120,593 $20.8 Million
Q1 2018 Apr 30, 2018	BUY	$135.59 - $157.16 $1.69 Million - $1.96 Million	12,492 Added 11.52%	120,893 $18.3 Million
Q4 2017 Feb 06, 2018	BUY	$131.06 - $150.39 $87,810 - $100,761	670 Added 0.62%	108,401 $14.6 Million
Q3 2017 Nov 08, 2017	BUY	$142.62 - $155.6 $15.4 Million - $16.8 Million	107,731	107,731 $15.8 Million

Others Institutions Holding JAZZ

# of Institutions

512

Shares Held

57.5M

Call Options Held

188K

Put Options Held

133K

View Full List

About Jazz Pharmaceuticals plc

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $7.71B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

More about JAZZ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Group LLC with notifications on news.

Account